opzelura
incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - muut dermatologiset valmisteet - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
wynzora 50 mikrog/g + 0.5 mg/g emulsiovoide
almirall s.a. - betamethasone dipropionate, calcipotriol - emulsiovoide - 50 mikrog/g + 0.5 mg/g - kalsipotrioli
quetiapin sandoz 25 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - quetiapini hemifumaras - tabletti, kalvopäällysteinen - 25 mg - ketiapiini
quetiapin sandoz 100 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - quetiapini hemifumaras - tabletti, kalvopäällysteinen - 100 mg - ketiapiini
quetiapin sandoz 200 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - quetiapini hemifumaras - tabletti, kalvopäällysteinen - 200 mg - ketiapiini
quetiapin sandoz 300 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - quetiapini hemifumaras - tabletti, kalvopäällysteinen - 300 mg - ketiapiini
quetiapin sandoz 200 mg depottabletti
sandoz a/s sandoz a/s - quetiapini fumaras - depottabletti - 200 mg - ketiapiini
quetiapin sandoz 300 mg depottabletti
sandoz a/s sandoz a/s - quetiapini fumaras - depottabletti - 300 mg - ketiapiini
quetiapin sandoz 400 mg depottabletti
sandoz a/s sandoz a/s - quetiapini fumaras - depottabletti - 400 mg - ketiapiini
quetiapin sandoz 50 mg depottabletti
sandoz a/s sandoz a/s - quetiapini hemifumaras - depottabletti - 50 mg - ketiapiini